Jane Street’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Jane Street’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,020	Closed	-$17K	–	11435
2021 Q4	$17K	Sell	3,020 -2,233	-43%	-$19K	﹤0.01%	9836
2021 Q3	$58K	Sell	5,253 -234	-4%	-$2.94K	﹤0.01%	9504
2021 Q2	$93K	Buy	+5,487	New	+$104K	﹤0.01%	9299
2020 Q3	–	Sell	-8,153	Closed	-$346K	–	8248
2020 Q2	$346K	Buy	+8,153	New	+$550K	﹤0.01%	5628

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Jane Street's EVFM Position: Q3 2022 in Review

Jane Street sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 56,339 shares — an estimated $64K sold.

Jane Street first reported a position in EVFM in Q2 2020 and held it in 5 quarters. The position peaked at $213K in Q2 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

Jane Street reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Jane Street sold 56,339 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $64K.
Jane Street first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Jane Street's Evofem Biosciences, Inc. Common Stock position peaked at $213K in Q2 2020.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.